News - Neurological, Adamas Pharmaceuticals


Popular Filters

Adamas Pharma earns $40 milestone in Forest deal


California, USA-based Adamas Pharmaceuticals revealed yesterday (January 9) that it has received $40…

Adamas PharmaceuticalsdonepezilFinancialForest LaboratoriesMDX-8704NamendaNeurologicalPharmaceuticalResearch

MannKind sells cancer drug rights to Colby; Forest licensing deal with Adamas


US drugmaker MannKind Corp (Nasdaq: MNKD) has licensed agreement exclusive worldwide rights to privately-held…

Adamas PharmaceuticalsColby PharmaceuticaldonepezilForest LaboratoriesLicensingMannKindMKC1106NamendaNeurologicalOncologyPharmaceutical

Back to top